| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |